Implications of oncogenomics for cancer research and clinical oncology

Cancer Journal

Volumn 7, Issue 1, 2001, Pages 40-51

  Herrmann, J L ^a   Rastelli, L ^a   Burgess, C E ^a   Fernandez, E E ^a   Gould Rothberg, B E ^a   Rothberg, J M ^a   Shimkets, R A ^a  

^a CURAGEN CORPORATION   (United States)

Author keywords

Cancer; Drug discovery; Gene expression; Oncogenomics; Oncology

Indexed keywords

BIOTECHNOLOGY; CANCER DIAGNOSIS; CANCER GENETICS; CANCER RESEARCH; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; GENOME; ONCOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW;

ANIMALS; CARCINOGENS; DRUG DESIGN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENOME, HUMAN; HUMANS; INFORMATION STORAGE AND RETRIEVAL; MEDICAL ONCOLOGY; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; PHARMACOGENETICS;

EID: 0035093042     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Therapeutic implications of the new biology
2. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
3. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
4. Proliferation-associated SNF2-like gene (PASG): A SNF2 family member altered in leukemia
5. Linking gene expression patterns to therapeutic groups in breast cancer
6. Gene expression analysis by transcript profiling coupled to a gene database query
7. Serial analysis of gene expression
8. Gene expression profiles in normal and cancer cells
9. A model for p53-induced apoptosis
10. Identification of c-MYC as a target of the APC pathway
11. The transcriptional program in the response of human fibroblasts to serum
12. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
13. Laser capture microdissection
14. Systematic and large-scale two-hybrid screens
15. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae
16. Single nucleotide polymorphism libraries: Why and how are we building them?
17. Genetic variants of CYP19 (aromatase) and breast cancer risk
18. Drug firms to create public database of genetic mutations
19. Integrating expression-based drug response and SNP-based pharmacogenetic strategies into a single comprehensive pharmocogenomics program
20. Pharmacogenomics: Translating functional genomics into rational therapeutics
21. Association of CYP3A4 genotype with treatment-related leukemia
22. Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance
23. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-transferase gene locus
24. Pharmacogenetics as a molecular basis for individualized drug therapy: The thiopurine S-methyltransferase paradigm
25. The genome sequence of Drosophila melanogaster
26. Pharmacogenomics: It's not just pharmacogenetics
27. Antineoplastic agents
28. Salvage therapy for ovarian cancer
29. Practice guidelines: Ovarian cancer